Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial-Reference-Cited by-同舟云学术

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Published:2000-05 Issue:10 Volume:7 Page:867-874
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Markert J M,Medlock M D,Rabkin S D,Gillespie G Y,Todo T,Hunter W D,Palmer C A,Feigenbaum F,Tornatore C,Tufaro F,Martuza R L

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301205.pdf

Reference23 articles.

1. Walker MD et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery New Engl J Med 1980 303: 1323–1329

2. Subach BR et al. Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series Neurosurgery 1999 45: 17–22; discussion 22–23

3. Prados MD et al. Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989 Int J Radiat Oncol Biol Phys 1992 23: 3–8

4. Chamberlain MC, Kormanik P . Salvage chemotherapy with taxol for recurrent anaplastic astrocytomas J Neurooncol 1999 43: 71–78

5. Martuza RL et al. Experimental therapy of human glioma by means of a genetically engineered virus mutant Science 1991 252: 854–856

Cited by 848 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements;Cancer Biomarkers;2024-08-04

2. Safety of non-replicative and oncolytic replication-selective HSV vectors;Trends in Molecular Medicine;2024-08

3. Advances in gene therapy for high-grade glioma: a review of the clinical evidence;Expert Review of Neurotherapeutics;2024-08

4. Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review;Annals of Medicine & Surgery;2024-07-17

5. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms;International Journal of Molecular Sciences;2024-06-19